SAMDaily.us | SNOTE | A | Justificaiton and Approval for Development and Domestic Manufacture of Adjuvanted Recombinant Pandemic Influenza Vaccines

SAMDAILY.US - ISSUE OF DECEMBER 26, 2019 SAM #6601
SPECIAL NOTICE

A -- Justificaiton and Approval for Development and Domestic Manufacture of Adjuvanted Recombinant Pandemic Influenza Vaccines

Notice Date: 12/24/2019 9:10:34 AM
Notice Type: Justification
NAICS: 325414 — Biological Product (except Diagnostic) Manufacturing
Contracting Office: OFFICE OF ACQ MGMT POLICY WASHINGTON DC 20201 USA
ZIP Code: 20201
Solicitation Number: 75A50120D00002
Archive Date: 01/23/2020
Point of Contact: James Harris, Enrique Manan
E-Mail Address: james.harris2@hhs.gov, enrique.manan@hhs.gov
(james.harris2@hhs.gov, enrique.manan@hhs.gov)
Award Number: 75A50120D00002
Award Date: 12/05/2019
Description: The purpose of this notice is to publicize the Justification and Approval for contract number 75A50120D00002, Development and Domestic Manufacture of�Adjuvanted, Recombinant Pandemic Influenza Vaccine, as required by FAR 6.305. �
Web Link: SAM.gov Permalink
(https://beta.sam.gov/opp/d5ba2a1b80814cfeaf88baca050e50cb/view)
Place of Performance: Address: Swiftwater, PA 18370, USA; Zip Code: 18370; Country: USA
Record: SN05523825-F 20191226/191224230131 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |